Evaluation of laboratory effectiveness of clopidogrel after elective endovascular procedures in patients with the history of the new coronavirus infection (COVID-19)

• Hauptverfasser: Natalia V. Kuchkina (Verfasst von), Nino V. Tsereteli (Verfasst von), Irina E. Chernysheva (Verfasst von), Elena I. Vorobyeva (Verfasst von), Irina V. Zubkova (Verfasst von), Sergey P. Semitko (Verfasst von), David G. Iosseliani (Verfasst von), Viktor V. Fomin (Verfasst von)
• Format: Buch
• Veröffentlicht: ZAO "Consilium Medicum", 2021-10-01T00:00:00Z.
• Schlagworte: article
• Online-Zugang: Connect to this object online.

Aim. To evaluate the impact of antiplatelet agent clopidogrel on the aggregation platelet activity in patients with the history of the new coronavirus infection (COVID-19). Materials and methods. The impact of clopidogrel on platelet aggregation was studied in 47 patients with coronary heart disease...